ACADIAN ASSET MANAGEMENT LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$63
-14.9%
4,563
-36.5%
0.00%
Q2 2023$74
+76.2%
7,187
+57.5%
0.00%
Q1 2023$42
-100.0%
4,563
-14.1%
0.00%
-100.0%
Q1 2018$264,000
-70.1%
5,315
-77.6%
0.00%
-75.0%
Q4 2017$884,000
+14.1%
23,740
-3.5%
0.00%
+33.3%
Q3 2017$775,00024,5930.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders